Preliminary research point out conolidine might inhibit specific ion channels, lowering neuronal excitability and restricting discomfort alerts. This system is especially applicable in neuropathic pain, where abnormal signaling results in persistent irritation. Additionally, conolidine appears to impact G protein-coupled receptor (GPCR) pathways in